Bosutinib (SKI-606)
Bosutinib (SKI-606) is a novel tyrosine kinase inhibitor. Bosutinib can overcome not only Bcr-Abl-dependent mechanisms of resistance, but also those that are Bcr-Abl-independent. It is used to treat patients with chronic myelogenous leukemia (CML) who demonstrate resistance to Imatinib or develop resistance during treatment.
Product Specifications
Shipping Conditions
RT
Storage Conditions
-20°C
Shelf Life
24months
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3878604 1.0 µg DNA
Klk4 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details MBS9933129 Inquire
Fish Mitochondrial Uncoupling Protein 1 (MUP1) ELISA Kit
Sign In for Pricing
View Details K2543202 1.0 µg DNA
TSPAN33 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details GTR15276337 1 Vial
Lentiviral mouse Rabl6 shRNA (UAS) - Lentiviral mouse Rabl6 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
K2572908 1.0 µg DNA
UBE2L3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details